Characteristics of Large-Vessel Occlusion Associated with COVID-19 and Ischemic Stroke

References

1. 1.↵
   1. Huang C,
   2. Wang Y,
   3. Li X, et al

   . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506 doi:10.1016/S0140-6736(20)30183-5 pmid:31986264

   CrossRefPubMed
2. 2.↵
   1. Guan WJ,
   2. Ni ZY,
   3. Hu Y, et al

   ; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–20 doi:10.1056/NEJMoa2002032 pmid:32109013

   CrossRefPubMed
3. 3.↵
   1. Mao L,
   2. Jin H,
   3. Wang M, et al

   . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683 doi:10.1001/jamaneurol.2020.1127 pmid:32275288

   CrossRefPubMed
4. 4.↵
   1. Zhou Y,
   2. Li W,
   3. Wang D, et al

   . Clinical time course of COVID-19, its neurological manifestation and some thoughts on its management. Stroke Vasc Neurol 2020;5:177–79 doi:10.1136/svn-2020-000398 pmid:32366614

   Abstract/FREE Full Text
5. 5.↵
   1. González‐Pinto T,
   2. Luna‐
   3. Rodríguez A,
   4. Moreno‐
   5. Estébanez A, et al

   . Emergency room neurology in times of COVID‐19: malignant ischemic stroke and SARS‐COV2 infection. Eur J Neurol 2020 April 30. [Epub ahead of print] doi:10.1111/ene.14286 pmid:32352618

   CrossRefPubMed
6. 6.↵
   1. Oxley TJ,
   2. Mocco J,
   3. Majidi S, et al

   . Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 2020;382:e60 doi:10.1056/NEJMc2009787 pmid:32343504

   CrossRefPubMed
7. 7.↵
   1. Qin C,
   2. Zhou L,
   3. Hu Z, et al

   . Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis 2020;71:762–68 doi:10.1093/cid/ciaa248 pmid:32161940

   CrossRefPubMed
8. 8.↵
   1. Zhang Y,
   2. Xiao M,
   3. Zhang S, et al

   . Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020;382:e38 doi:10.1056/NEJMc2007575 pmid:32268022

   CrossRefPubMed
9. 9.↵
   1. Adams HP Jr.,
   2. Bendixen BH,
   3. Kappelle LJ, et al

   . Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial—TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35–41 doi:10.1161/01.str.24.1.35 pmid:7678184

   Abstract/FREE Full Text
10. 10.↵
    1. Jozwiak BP,
    2. Kumar V,
    3. Hussain S, et al

    . Cleveland Clinic Abu Dhabi stroke registry (CCADSR) young ischemic strokes: initial results. J Neurol Sciences 2019;405:85 doi:10.1016/j.jns.2019.10.586

    CrossRef
11. 11.↵
    1. Khan M,
    2. Hashim H,
    3. Nisa Z, et al

    . Thrombolysis for acute ischemic stroke: experience in Dubai, and comparison of Arab with non-Arab population. J Neurol Stroke 2016;4:00156 doi:10.15406/jnsk.2016.04.00156

    CrossRef
12. 12.↵
    1. Beyrouti R,
    2. Adams ME,
    3. Benjamin L, et al

    . Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry 2020;91:889–91 doi:10.1136/jnnp-2020-323586 pmid:32354768

    FREE Full Text
13. 13.↵
    1. Aggarwal G,
    2. Lippi G,
    3. Michael Henry B

    . Cerebrovascular disease is associated with an increased disease severity in patients with coronavirus disease 2019 (COVID-19): a pooled analysis of published literature. Int J Stroke 2020;15:385–89 doi:10.1177/1747493020921664 pmid:32310015

    CrossRefPubMed
14. 14.↵
    1. Avula A,
    2. Nalleballe K,
    3. Narula N, et al

    . COVID 19 presenting as stroke. Brain Behav Immun 2020;87:115–19 doi:10.1016/j.bbi.2020.04.077 pmid:32360439

    CrossRefPubMed
15. 15.↵
    1. Lodigiani C,
    2. Iapichino G,
    3. Carenzo L, et al

    ; Humanitas COVID-19 Task Force. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 2020;191:9–14 doi:10.1016/j.thromres.2020.04.024 pmid:32353746

    CrossRefPubMed
16. 16.↵
    1. Chen G,
    2. Wu D,
    3. Guo W, et al

    . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 2020;130:2620–29 doi:10.1172/JCI137244 pmid:32217835

    CrossRefPubMed
17. 17.↵
    1. Tang N,
    2. Li D,
    3. Wang X, et al

    . Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020;18:844–47 doi:10.1111/jth.14768 pmid:32073213

    CrossRefPubMed
18. 18.↵
    1. Yaghi S,
    2. Ishida K,
    3. Torres J, et al

    . SARS2-CoV-2 and stroke in a New York healthcare system. Stroke 2020;51:2002–11 doi:10.1161/STROKEAHA.120.030335 pmid:32432996

    CrossRefPubMed
19. 19.↵
    1. Sweid A,
    2. Hammoud B,
    3. Weinberg JH, et al

    . Thrombotic neurovascular disease in COVID-19 patients. Neurosurgery 2020 June 4. [Epub ahead of print] doi:10.1093/neuros/nyaa254 pmid:32496534

    CrossRefPubMed
20. 20.↵
    1. Kerleroux B,
    2. Fabacher T,
    3. Bricout N, et al

    ; SFNR, the ETIS registry, and the JENI-Research Collaborative. Mechanical thrombectomy for acute ischemic stroke amid the COVID-19 outbreak: decreased activity, and increased care delays. Stroke 2020;51:2012–17 doi:10.1161/STROKEAHA.120.030373 pmid:32432994

    CrossRefPubMed